首页 > 最新文献

Clinics in dermatology最新文献

英文 中文
Mpox (monkeypox). Mpox (monkeypox)。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-24 DOI: 10.1016/j.clindermatol.2025.09.011
Joseph Heskin, Ien Chan, Christopher Barry Bunker, Christopher James Scott

Mpox, a zoonotic orthopoxvirus, originally identified in 1958, exhibits two distinct genetic strains or clades, clades 1 and 2. Before 2022, mpox was predominantly isolated in the endemic regions of West and Central Africa. Sporadic outbreaks of travel-associated clade 2 mpox had previously occurred in nonendemic areas, but persistent human-to-human transmission within nonendemic regions had not been documented until recently.

Mpox是一种人畜共患的正痘病毒,最初于1958年发现,表现出两个不同的遗传株或进化枝,进化枝1和进化枝2。在2022年之前,麻疹主要在西非和中非流行区域被隔离。以前在非流行地区曾发生过与旅行相关的2支mpox散发疫情,但直到最近才有在非流行地区持续的人际传播的记录。2022年5月,出现了全球麻疹疫情,影响了全世界100多个国家。这促使世界卫生组织宣布mpox为国际关注的突发公共卫生事件。
{"title":"Mpox (monkeypox).","authors":"Joseph Heskin, Ien Chan, Christopher Barry Bunker, Christopher James Scott","doi":"10.1016/j.clindermatol.2025.09.011","DOIUrl":"10.1016/j.clindermatol.2025.09.011","url":null,"abstract":"<p><p>Mpox, a zoonotic orthopoxvirus, originally identified in 1958, exhibits two distinct genetic strains or clades, clades 1 and 2. Before 2022, mpox was predominantly isolated in the endemic regions of West and Central Africa. Sporadic outbreaks of travel-associated clade 2 mpox had previously occurred in nonendemic areas, but persistent human-to-human transmission within nonendemic regions had not been documented until recently.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145174067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinics in Dermatology: Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus). 皮肤科诊所:单纯疱疹(性病和艾滋病毒皮肤病方面的更新)需要一些图片。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-24 DOI: 10.1016/j.clindermatol.2025.09.010
Emily Clarke

Herpes simplex virus (HSV) is the most common cause of anogenital ulceration worldwide. There are two distinct viruses: HSV-1 associated with oro-labial cold sores and genital infection and HSV-2 associated with genital infection. Infection is lifelong, and typically presents with painful anogenital ulceration, which may recur after periods of latency. Asymptomatic shedding is common and may lead to transmission to sexual partners. Antiviral suppression with aciclovir, valaciclovir, or famciclovir is useful to treat initial painful episodes or troublesome recurrent infection. Suppressive antiviral therapy, condoms, selective abstinence, and disclosure to sexual partners have all been demonstrated to reduce the risk of transmission.

单纯疱疹病毒(HSV)是世界范围内引起肛门生殖器溃疡的最常见原因。有两种不同的病毒:1型单纯疱疹病毒与口腔唇疱疹和生殖器感染有关,2型单纯疱疹病毒与生殖器感染有关。感染是终身的,通常表现为疼痛的肛门生殖器溃疡,潜伏期后可能复发。无症状脱落是常见的,并可能导致传播给性伴侣。阿昔洛韦、伐昔洛韦或泛环洛韦的抗病毒抑制对治疗最初的疼痛发作或麻烦的复发性感染是有用的。抑制性抗病毒治疗、避孕套、选择性禁欲和向性伴侣披露都已被证明可以降低传播风险。
{"title":"Clinics in Dermatology: Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus).","authors":"Emily Clarke","doi":"10.1016/j.clindermatol.2025.09.010","DOIUrl":"10.1016/j.clindermatol.2025.09.010","url":null,"abstract":"<p><p>Herpes simplex virus (HSV) is the most common cause of anogenital ulceration worldwide. There are two distinct viruses: HSV-1 associated with oro-labial cold sores and genital infection and HSV-2 associated with genital infection. Infection is lifelong, and typically presents with painful anogenital ulceration, which may recur after periods of latency. Asymptomatic shedding is common and may lead to transmission to sexual partners. Antiviral suppression with aciclovir, valaciclovir, or famciclovir is useful to treat initial painful episodes or troublesome recurrent infection. Suppressive antiviral therapy, condoms, selective abstinence, and disclosure to sexual partners have all been demonstrated to reduce the risk of transmission.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145174069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updates on Kaposi sarcoma. 卡波西肉瘤最新进展
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-24 DOI: 10.1016/j.clindermatol.2025.09.013
Kyaw Zin Htet, Eman Bahrani, Kieron S Leslie

Kaposi sarcoma (KS) is an angioproliferative tumor that is associated with human herpesvirus 8 or Kaposi sarcoma-associated herpes virus infection. KS typically presents in the skin as isolated or multiple, violaceous macules or papulonodular lesions or plaques. The four different KS clinical categories-classic, endemic, epidemic, or AIDS-related and iatrogenic KS-are heterogeneous in epidemiology, manifestations, and complications. Clinical features, diagnostic modalities, and therapeutic regimens for all types of KS are summarized in this review. It is important for clinicians to promptly recognize and approach the treatment of KS in a multidisciplinary fashion for optimal therapeutic outcomes. Newer targeted therapies based on its pathogenesis are being studied. Kaposi sarcoma (KS) is a vascular tumor associated with human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma-associated herpesvirus (KSHV) infection. KS was first documented in 1872 by Moritz Kaposi, (1837-1902) a Hungarian dermatologist and physician, who described five cases of an atypical tumor that primarily affected the skin of the lower extremities of elderly men.1 He described the tumors as "idiopathic multiple pigmented sarcoma of the skin," and this form of the disease later became known as sporadic or classic KS.1.

卡波西肉瘤(KS)是一种血管增生性肿瘤,与人类疱疹病毒8 (HHV-8)或卡波西肉瘤相关疱疹病毒(KSHV)感染有关。KS通常在皮肤上表现为孤立或多发的紫色斑疹或丘疹样病变或斑块。典型性KS、地方性KS、流行或艾滋病相关KS和医源性KS这四种不同的临床类型在流行病学、表现和并发症方面具有异质性。本文综述了各种类型KS的临床特点、诊断方式和治疗方案。对于临床医生来说,及时认识到并以多学科的方式治疗KS是很重要的,以获得最佳的治疗结果。基于其发病机制的新的靶向治疗正在研究中。
{"title":"Updates on Kaposi sarcoma.","authors":"Kyaw Zin Htet, Eman Bahrani, Kieron S Leslie","doi":"10.1016/j.clindermatol.2025.09.013","DOIUrl":"10.1016/j.clindermatol.2025.09.013","url":null,"abstract":"<p><p>Kaposi sarcoma (KS) is an angioproliferative tumor that is associated with human herpesvirus 8 or Kaposi sarcoma-associated herpes virus infection. KS typically presents in the skin as isolated or multiple, violaceous macules or papulonodular lesions or plaques. The four different KS clinical categories-classic, endemic, epidemic, or AIDS-related and iatrogenic KS-are heterogeneous in epidemiology, manifestations, and complications. Clinical features, diagnostic modalities, and therapeutic regimens for all types of KS are summarized in this review. It is important for clinicians to promptly recognize and approach the treatment of KS in a multidisciplinary fashion for optimal therapeutic outcomes. Newer targeted therapies based on its pathogenesis are being studied. Kaposi sarcoma (KS) is a vascular tumor associated with human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma-associated herpesvirus (KSHV) infection. KS was first documented in 1872 by Moritz Kaposi, (1837-1902) a Hungarian dermatologist and physician, who described five cases of an atypical tumor that primarily affected the skin of the lower extremities of elderly men.<sup>1</sup> He described the tumors as \"idiopathic multiple pigmented sarcoma of the skin,\" and this form of the disease later became known as sporadic or classic KS.<sup>1</sup>.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145174020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human papillomavirus: An update. HPV:最新进展。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-24 DOI: 10.1016/j.clindermatol.2025.09.012
Manik Kohli, Christopher B Bunker, Georgios Kravvas

Human papillomaviruses (HPV) comprise a group of DNA viruses with more than 450 types identified. HPV represents one of the most common viral infections globally. HPV can cause a wide spectrum of clinical disease depending on type, including benign lesions (cutaneous or anogenital warts), premalignant lesions (intraepithelial neoplasia), and anogenital cancers; however, infection may also frequently remain subclinical. Even though the role of HPV in the pathogenesis of penile, vulval, and anal intraepithelial neoplasia and other cutaneous diseases has been recognized, robust evidence for the role of screening and effective management is often lacking. The implementation of prophylactic vaccination for young people and at-risk adults in high-income countries has proven successful, and now there is growing interest in postexposure vaccination.

人乳头瘤病毒(HPV)是一组DNA病毒,已确定的类型超过450种。HPV是全球最常见的病毒感染之一。HPV可根据类型引起广泛的临床疾病,包括良性病变(皮肤或肛门生殖器疣),恶性前病变(上皮内瘤变)和肛门生殖器癌;然而,感染也可能经常是亚临床的。尽管HPV在阴茎、外阴和肛门上皮内瘤变和其他皮肤病的发病机制中的作用已经得到承认,但通常缺乏筛查和有效管理的有力证据。事实证明,在高收入国家对年轻人和高危成年人实施预防性疫苗接种是成功的,现在人们对接触后疫苗接种的兴趣越来越大。
{"title":"Human papillomavirus: An update.","authors":"Manik Kohli, Christopher B Bunker, Georgios Kravvas","doi":"10.1016/j.clindermatol.2025.09.012","DOIUrl":"10.1016/j.clindermatol.2025.09.012","url":null,"abstract":"<p><p>Human papillomaviruses (HPV) comprise a group of DNA viruses with more than 450 types identified. HPV represents one of the most common viral infections globally. HPV can cause a wide spectrum of clinical disease depending on type, including benign lesions (cutaneous or anogenital warts), premalignant lesions (intraepithelial neoplasia), and anogenital cancers; however, infection may also frequently remain subclinical. Even though the role of HPV in the pathogenesis of penile, vulval, and anal intraepithelial neoplasia and other cutaneous diseases has been recognized, robust evidence for the role of screening and effective management is often lacking. The implementation of prophylactic vaccination for young people and at-risk adults in high-income countries has proven successful, and now there is growing interest in postexposure vaccination.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145174009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The dermatologic aspects of sexually transmitted infections and human immunodeficiency virus: Part II. 性传播感染和艾滋病毒的皮肤病学方面:第二部分。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-23 DOI: 10.1016/j.clindermatol.2025.09.005
Christopher B Bunker, David A Hawkins
{"title":"The dermatologic aspects of sexually transmitted infections and human immunodeficiency virus: Part II.","authors":"Christopher B Bunker, David A Hawkins","doi":"10.1016/j.clindermatol.2025.09.005","DOIUrl":"10.1016/j.clindermatol.2025.09.005","url":null,"abstract":"","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovations and Insights from the 16th World Congress of the International Academy of Cosmetic Dermatology held in Budapest, Hungary, June 26 to 28, 2025. 2025年6月26日至28日在匈牙利布达佩斯举行的第16届国际美容皮肤科学会世界大会的创新和见解。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-20 DOI: 10.1016/j.clindermatol.2025.09.004
Vesna Petronic-Rosic, Norbert Kiss
{"title":"Innovations and Insights from the 16th World Congress of the International Academy of Cosmetic Dermatology held in Budapest, Hungary, June 26 to 28, 2025.","authors":"Vesna Petronic-Rosic, Norbert Kiss","doi":"10.1016/j.clindermatol.2025.09.004","DOIUrl":"10.1016/j.clindermatol.2025.09.004","url":null,"abstract":"","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatology misinformation on the Chinese social media platform known as RedNote/Xiaohongshu. 中国社交媒体平台红笔记/小红书上的皮肤病错误信息。
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-13 DOI: 10.1016/j.clindermatol.2025.09.003
Tsz Lam, Uwe Wollina, Leonard J Hoenig, Lawrence Charles Parish

Social media has led to the proliferation of accessible health and dermatologic advice; however, it has also permitted the spread of misinformation. We have examined the prevalence of dermatologic misinformation on the popular Chinese social media and e-commerce platform Xiaohongshu (RedNote), which has a notable and significant impact on Western audiences. Through an analysis of the digital content and media posts on RedNote as well as an examination of related scientific literature, this study identifies and reviews distinct examples of dermatology advice promoted by the RedNote platform. Key findings highlight the combination of aggressive ingredients, irregular homemade treatments, and the endorsement of alarming beauty procedures. Algorithmically structured platforms like RedNote prioritize online engagement over factual evidence. When merged with the consumer-oriented culture and the necessary high beauty standards, the result fosters an environment where false information can expand and thrive. Our analysis revealed a public health concern where social platforms and influencer culture contribute to cutaneous health hazards. We have proposed some practical solutions, emphasizing the importance of elevated media literacy among social community spaces and vocalized professional intervention. These measures should mitigate the harmful consequences originating from online misinformation.

社交媒体导致了健康和皮肤病学咨询的普及;然而,它也允许了错误信息的传播。我们调查了流行的中国社交媒体和电子商务平台小红书(RedNote)上皮肤病学错误信息的流行程度,这些信息对西方受众产生了显著而显著的影响。通过对RedNote上的数字内容和媒体帖子的分析,以及对相关科学文献的研究,本研究确定并回顾了RedNote平台推广的皮肤病学建议的不同例子。主要研究结果强调了攻击性成分、不规律的家庭护理和令人担忧的美容程序的认可的结合。像RedNote这样的算法结构化平台优先考虑在线参与,而不是事实证据。当与以消费者为导向的文化和必要的高审美标准相结合时,这就形成了一个虚假信息可以扩大和繁荣的环境。我们的分析揭示了社交平台和网红文化对皮肤健康危害的公共健康问题。我们提出了一些实用的解决方案,强调在社会社区空间中提高媒体素养和专业干预的重要性。这将减轻网络错误信息带来的有害后果。
{"title":"Dermatology misinformation on the Chinese social media platform known as RedNote/Xiaohongshu.","authors":"Tsz Lam, Uwe Wollina, Leonard J Hoenig, Lawrence Charles Parish","doi":"10.1016/j.clindermatol.2025.09.003","DOIUrl":"10.1016/j.clindermatol.2025.09.003","url":null,"abstract":"<p><p>Social media has led to the proliferation of accessible health and dermatologic advice; however, it has also permitted the spread of misinformation. We have examined the prevalence of dermatologic misinformation on the popular Chinese social media and e-commerce platform Xiaohongshu (RedNote), which has a notable and significant impact on Western audiences. Through an analysis of the digital content and media posts on RedNote as well as an examination of related scientific literature, this study identifies and reviews distinct examples of dermatology advice promoted by the RedNote platform. Key findings highlight the combination of aggressive ingredients, irregular homemade treatments, and the endorsement of alarming beauty procedures. Algorithmically structured platforms like RedNote prioritize online engagement over factual evidence. When merged with the consumer-oriented culture and the necessary high beauty standards, the result fosters an environment where false information can expand and thrive. Our analysis revealed a public health concern where social platforms and influencer culture contribute to cutaneous health hazards. We have proposed some practical solutions, emphasizing the importance of elevated media literacy among social community spaces and vocalized professional intervention. These measures should mitigate the harmful consequences originating from online misinformation.</p>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145069209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The state of artificial intelligence-enabled skin cancer diagnostics: Why are there two spectroscopy devices available yet no imaging devices? 人工智能皮肤癌诊断的现状:为什么有两种光谱设备可用,而没有成像设备?
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-01 DOI: 10.1016/j.clindermatol.2025.05.001
Jay Gopal BS , Albert E. Zhou MD, PhD , Ashfaq A. Marghoob MD , Christian Gronbeck MD , Jane M. Grant-Kels MD
Artificial intelligence (AI) is already impacting the way we diagnose skin diseases. Although there are many new AI tools promoted to be helpful to dermatologists and primary care physicians, especially in the recognition of melanoma and nonmelanoma skin cancers, there is a major obstacle that the sponsoring companies must overcome before it is possible to integrate any of these innovative AI-enabled technologies into clinical practice. The regulatory process of the Food and Drug Administration (FDA) is demanding and requires proof of safety and effectiveness for each of these devices before the FDA gives their approval. Herein we discuss the reasons why there are hundreds of papers applying AI to imaging in dermatology, but the only available FDA-approved AI dermatology tools use spectroscopy.
人工智能(AI)已经在影响我们诊断皮肤病的方式。尽管有许多新的人工智能工具被吹捧为对皮肤科医生和初级保健医生有帮助,特别是在识别黑色素瘤和非黑色素瘤皮肤癌方面,但在将这些创新的人工智能(AI)支持技术整合到临床实践之前,赞助公司必须克服一个主要障碍。美国食品和药物管理局(FDA)的监管程序要求严格,在批准之前需要证明每种设备的安全性和有效性。在这里,我们讨论了为什么有数百篇论文将人工智能应用于皮肤科成像,但唯一可用的fda批准的人工智能皮肤科工具使用光谱学的原因。
{"title":"The state of artificial intelligence-enabled skin cancer diagnostics: Why are there two spectroscopy devices available yet no imaging devices?","authors":"Jay Gopal BS ,&nbsp;Albert E. Zhou MD, PhD ,&nbsp;Ashfaq A. Marghoob MD ,&nbsp;Christian Gronbeck MD ,&nbsp;Jane M. Grant-Kels MD","doi":"10.1016/j.clindermatol.2025.05.001","DOIUrl":"10.1016/j.clindermatol.2025.05.001","url":null,"abstract":"<div><div><span>Artificial intelligence (AI) is already impacting the way we diagnose skin diseases. Although there are many new AI tools promoted to be helpful to dermatologists and </span>primary care<span><span> physicians, especially in the recognition of melanoma and </span>nonmelanoma skin cancers<span>, there is a major obstacle that the sponsoring companies must overcome before it is possible to integrate any of these innovative AI-enabled technologies into clinical practice. The regulatory process of the Food and Drug Administration (FDA) is demanding and requires proof of safety and effectiveness for each of these devices before the FDA gives their approval. Herein we discuss the reasons why there are hundreds of papers applying AI to imaging in dermatology, but the only available FDA-approved AI dermatology tools use spectroscopy.</span></span></div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 687-689"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143971705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prurigo nodularis and acquired perforating dermatosis in chronic kidney disease: Are they the same entity? 慢性肾脏疾病的结节性痒疹和获得性穿孔性皮肤病:它们是同一个实体吗?
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-01 DOI: 10.1016/j.clindermatol.2025.03.011
Rami H. Mahmoud BS , Giulia Coscarella MD , Ruby Kwak MD , Gil Yosipovitch MD
Prurigo nodularis has been reported in itchy chronic kidney disease (CKD) patients, particularly those with end-stage renal failure. Acquired perforating dermatitis associated with CKD and diabetes is a group of disorders in which dermal materials are eliminated through the epidermis and is characterized by itchy papules and nodules. We focus on the relationship between prurigo nodularis and acquired perforating dermatitis in CKD and provide data to support that both entities share many of the same clinical and histologic features. These cutaneous diseases are often underreported in this patient population, leading to inadequate treatment and suboptimal patient outcomes. Our review of the literature suggests a relationship between prurigo nodularis/acquired perforating dermatitis and CKD, presumably driven by uremic pruritus, changes in the renin-angiotensin-aldosterone system, a predisposing immune dysregulation with increased interleukin-31 expression, and opioid system imbalances. A variety of pharmacologic therapies may be efficacious. The use of the new targeted biologics for prurigo nodularis and whether they are also helpful for CKD and acquired perforating dermatitis are welcome.
痒性慢性肾脏疾病(CKD)患者,特别是终末期肾功能衰竭患者中有结节性痒疹(PN)的报道。与CKD和糖尿病相关的获得性穿孔性皮炎(APD)是一组皮肤物质通过表皮消除的疾病,其特征是发痒的丘疹和结节。我们关注CKD中PN和APD之间的关系,并提供数据来支持这两种实体具有许多相同的临床和组织学特征。这些皮肤疾病在这一患者群体中往往报告不足,导致治疗不足和患者预后不佳。我们对文献的回顾表明PN/APD和CKD之间的关系,可能是由尿毒症瘙痒、肾素-血管紧张素-醛固酮系统的变化、IL-31表达增加的易感免疫失调和阿片系统失衡驱动的。多种药物治疗可能有效。新的靶向生物制剂在PN中的应用,以及它们是否对CKD和APD也有帮助,都是值得欢迎的。
{"title":"Prurigo nodularis and acquired perforating dermatosis in chronic kidney disease: Are they the same entity?","authors":"Rami H. Mahmoud BS ,&nbsp;Giulia Coscarella MD ,&nbsp;Ruby Kwak MD ,&nbsp;Gil Yosipovitch MD","doi":"10.1016/j.clindermatol.2025.03.011","DOIUrl":"10.1016/j.clindermatol.2025.03.011","url":null,"abstract":"<div><div><span><span>Prurigo nodularis has been reported in itchy </span>chronic kidney disease<span> (CKD) patients, particularly those with end-stage renal failure. Acquired perforating dermatitis associated with CKD and diabetes is a group of disorders in which dermal materials are eliminated through the epidermis and is characterized by itchy papules and nodules. We focus on the relationship between prurigo nodularis and acquired perforating dermatitis in CKD and provide data to support that both entities share many of the same clinical and histologic features. These cutaneous diseases are often underreported in this patient population, leading to inadequate treatment and suboptimal patient outcomes. Our review of the literature suggests a relationship between prurigo nodularis/acquired perforating dermatitis and CKD, presumably driven by </span></span>uremic pruritus<span>, changes in the renin-angiotensin-aldosterone system, a predisposing immune dysregulation<span> with increased interleukin-31 expression, and opioid system imbalances. A variety of pharmacologic therapies may be efficacious. The use of the new targeted biologics for prurigo nodularis and whether they are also helpful for CKD and acquired perforating dermatitis are welcome.</span></span></div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 644-648"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prurigo nodularis imitators unmasked
IF 2.2 4区 医学 Q2 DERMATOLOGY Pub Date : 2025-09-01 DOI: 10.1016/j.clindermatol.2025.03.003
Elisabeth V. Goessinger MD , Tobias Kliesener MD , Beda Muehleisen MD, Oliver Brandt MD, Simon Mueller MD
Prurigo nodularis (PN) is characterized by chronic, nodular lesions on the extensor surfaces of the extremities and back. For experienced clinicians, the recognition of this diagnosis is usually not difficult; however, it is essential to consider differential diagnoses and to identify PN imitators. We report five patients with severe chronic pruritus who presented with skin lesions resembling PN. They were treated accordingly but were subsequently diagnosed with a different underlying disease, including nodular marginal zone lymphoma (1 case), delusional parasitosis (1 case), well-differentiated squamous cell carcinomas arising among PN lesions (2 cases), and PN-like pemphigus foliaceus (1 case). Critical reassessment of the diagnosis of PN is important to avoid cognitive biases such as the availability bias, anchoring bias, or attribution bias, which could lead to delayed diagnosis of the actual disease, inappropriate treatment, and poorer outcome.
结节性痒疹(PN)的特征是四肢和背部伸肌表面的典型慢性结节性病变。对于经验丰富的临床医生来说,识别这种诊断通常并不困难;然而,必须考虑鉴别诊断和识别PN模仿者。我们报告了5例严重慢性瘙痒患者,他们的皮肤病变类似PN。他们接受了相应的治疗,但随后被诊断为不同的基础疾病,包括结节性边缘区淋巴瘤(1例),妄想寄生虫病(1例),PN病变中出现的高分化鳞状细胞癌(2例)和PN样天疱疮(1例)。对PN诊断进行批判性重新评估对于避免认知偏差(如可得性偏差、锚定偏差或归因偏差)非常重要,这些偏差可能导致实际疾病的诊断延迟、治疗不当和预后较差。
{"title":"Prurigo nodularis imitators unmasked","authors":"Elisabeth V. Goessinger MD ,&nbsp;Tobias Kliesener MD ,&nbsp;Beda Muehleisen MD,&nbsp;Oliver Brandt MD,&nbsp;Simon Mueller MD","doi":"10.1016/j.clindermatol.2025.03.003","DOIUrl":"10.1016/j.clindermatol.2025.03.003","url":null,"abstract":"<div><div><span><span><span><span>Prurigo nodularis<span> (PN) is characterized by chronic, nodular lesions on the extensor surfaces of the extremities and back. For experienced clinicians, the recognition of this diagnosis is usually not difficult; however, it is essential to consider differential diagnoses and to identify PN imitators. We report five patients with severe chronic pruritus who presented with skin lesions resembling PN. They were treated accordingly but were subsequently diagnosed with a different underlying disease, including nodular </span></span>marginal zone lymphoma (1 case), </span>delusional parasitosis (1 case), well-differentiated squamous cell carcinomas arising among PN lesions (2 cases), and PN-like </span>pemphigus foliaceus (1 case). Critical reassessment of the diagnosis of PN is important to avoid cognitive biases such as the availability bias, </span>anchoring bias<span>, or attribution bias, which could lead to delayed diagnosis of the actual disease, inappropriate treatment, and poorer outcome.</span></div></div>","PeriodicalId":10358,"journal":{"name":"Clinics in dermatology","volume":"43 5","pages":"Pages 633-639"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinics in dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1